Neurotrope, Inc. announced that Paula T. Trzepacz, M.D., has joined Neurotrope BioScience, Inc. as its Executive Vice President and Chief Medical Officer. Prior to joining Neurotrope, Dr. Trzepacz was at Eli Lilly and Company for over 15 years where she was most recently a Senior Medical Fellow in Neurosciences drug development. She served on the global drug development team for Amyvid, the PET radiotracer indicated for estimation of beta-amyloid plaque density in brains of cognitively impaired persons suspected of having Alzheimer's disease.